Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$342M |
| 2 |
NVIDIA
NVDA
|
+$330M |
| 3 |
Capital One
COF
|
+$288M |
| 4 |
Johnson & Johnson
JNJ
|
+$169M |
| 5 |
AMRZ
Amrize Ltd
AMRZ
|
+$164M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.01B |
| 2 |
Microsoft
MSFT
|
+$999M |
| 3 |
DFS
Discover Financial Services
DFS
|
+$296M |
| 4 |
Eli Lilly
LLY
|
+$215M |
| 5 |
Amazon
AMZN
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.29% |
| 2 | Financials | 13.54% |
| 3 | Consumer Discretionary | 9.85% |
| 4 | Healthcare | 9.21% |
| 5 | Communication Services | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Franklin Covey
FC
$242M
| $28.1K | ﹤0.01% |
1,231
-1,706
| -58% | -$37.7K |
|
2877
American Coastal Insurance
ACIC
$495M
| $28.1K | ﹤0.01% |
2,526
-5,437
| -68% | -$59.9K |
|
2878
Lightbridge
LTBR
$305M
| $27.9K | ﹤0.01% |
+2,088
| New | +$23K |
|
2879
Gevo
GEVO
$387M
| $27.8K | ﹤0.01% |
+21,073
| New | +$24.7K |
|
|
ORKA
2880
Oruka Therapeutics
ORKA
$5.88B
| $27.8K | ﹤0.01% |
+2,477
| New | +$25.8K |
|
2881
West Bancorporation
WTBA
$484M
| $27.7K | ﹤0.01% |
1,413
+52
| +4% | +$1K |
|
2882
Southern First Bancshares
SFST
$601M
| $27.6K | ﹤0.01% |
726
| – | – |
|
2883
Aquestive Therapeutics
AQST
$489M
| $27.5K | ﹤0.01% |
8,311
+1,421
| +21% | +$4.08K |
|
2884
Organogenesis Holdings
ORGO
$217M
| $27.4K | ﹤0.01% |
7,478
+1,189
| +19% | +$4.43K |
|
2885
Abeona Therapeutics
ABEO
$409M
| $27.3K | ﹤0.01% |
+4,815
| New | +$27.4K |
|
|
KWY
2886
Kingsway Corp
KWY
$286M
| $27.2K | ﹤0.01% |
2,009
+800
| +66% | +$8.5K |
|
2887
BayCom
BCML
$334M
| $27.1K | ﹤0.01% |
979
| – | – |
|
|
ITOS
2888
DELISTED
iTeos Therapeutics
ITOS
| $27.1K | ﹤0.01% |
2,717
+345
| +15% | +$2.78K |
|
2889
Maravai LifeSciences
MRVI
$895M
| $26.9K | ﹤0.01% |
11,149
-111,244
| -91% | -$234K |
|
2890
Paysign
PAYS
$678M
| $26.9K | ﹤0.01% |
3,731
-136
| -4% | -$487 |
|
2891
El Pollo Loco
LOCO
$471M
| $26.8K | ﹤0.01% |
2,433
| – | – |
|
2892
Viemed Healthcare
VMD
$370M
| $26.8K | ﹤0.01% |
3,872
+354
| +10% | +$2.4K |
|
|
CAI
2893
Caris Life Sciences
CAI
$6.2B
| $26.7K | ﹤0.01% |
+1,000
| New | +$26.9K |
|
2894
Satellogic
SATL
$809M
| $26.6K | ﹤0.01% |
+7,383
| New | +$27.8K |
|
2895
OptimizeRx
OPRX
$131M
| $26.5K | ﹤0.01% |
1,962
-219
| -10% | -$2.4K |
|
2896
Aviat Networks
AVNW
$273M
| $26.2K | ﹤0.01% |
1,088
| – | – |
|
2897
Gossamer Bio
GOSS
$87.2M
| $26K | ﹤0.01% |
+21,159
| New | +$23.1K |
|
2898
Atea Pharmaceuticals
AVIR
$408M
| $26K | ﹤0.01% |
7,216
| – | – |
|
2899
Colony Bankcorp
CBAN
$465M
| $26K | ﹤0.01% |
1,577
| – | – |
|
|
TBRG
2900
DELISTED
TruBridge
TBRG
| $26K | ﹤0.01% |
+1,109
| New | +$27.2K |
|
Similar funds
Legal & General Group's Q2 2025 Portfolio in Review
As of Q2 2025, Legal & General Group held 3,602 positions worth $403B, up 9.7% from $367B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Legal & General Group's Q2 2025 filing shows 227 new, 1,896 increased, 1,081 reduced and 186 closed positions. Its largest new stake was Amrize Ltd: 3,253,080 shares worth $162M. The largest sale was Apple, an estimated $1.01B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Financials and Consumer Discretionary.
- Legal & General Group's largest Q2 2025 buy was Amrize Ltd: 3,253,080 shares worth $162M.
- Legal & General Group added most to Tesla in Q2 2025, an estimated $342M increase.
- Legal & General Group's biggest Q2 2025 reduction was Apple, cutting an estimated $1.01B.
- Legal & General Group fully exited Discover Financial Services in Q2 2025, selling an estimated $296M.
- Legal & General Group's ten largest holdings make up 32% of its $403B portfolio in Q2 2025.
- Legal & General Group opened 227 new positions and closed 186 in Q2 2025.
- Legal & General Group's portfolio value rose 9.7% quarter-over-quarter to $403B.
Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.